Step 1 topics → Neurology and Special Senses → Anesthetics (Local, General) and Muscle Relaxants

Anesthetics (Local, General) and Muscle Relaxants

USMLE Step 1 trap: Reverses the order of nerve fiber blockade by local anesthetics, placing motor before sensory. Local anesthetics block small, unmyelinated or lightly myelinated fibers first; the order is pain/temperature (C, Aδ) → autonomic → touch/pressure → motor (Aα last).

Anesthetics and muscle relaxants are tested on USMLE Step 1 more mechanistically than most students expect. The exam doesn't just ask you to name drugs — it gives you a clinical scenario and asks you to predict what happens when something goes wrong, or to choose the right drug for a patient with a specific condition. That means you need to know why local anesthetics block pain before motor, why succinylcholine can't be reversed, and exactly what dantrolene is doing at the molecular level. The also-known-as list here is your hit list: lidocaine, bupivacaine, propofol, ketamine, etomidate, succinylcholine, rocuronium, dantrolene. Know each one cold.

The trickiest parts of this topic cluster around two themes: reversal and order. Students mix up which blockers can be reversed (only nondepolarizing ones), and they mix up the order of local anesthetic fiber blockade (pain goes first, motor goes last — the opposite of what feels intuitive). USMLE Step 1 exploits both of these. You'll also see metabolism questions where the answer hinges on whether the drug is an ester or an amide — a distinction that's easy to memorize but often forgotten under pressure.

For general anesthetics, the exam loves ketamine and etomidate for their unique profiles: ketamine causes dissociative anesthesia and increases secretions and blood pressure (useful in hypotensive patients), while etomidate suppresses adrenal cortisol synthesis and is the go-to for hemodynamically unstable patients. Malignant hyperthermia is a high-yield emergency scenario where USMLE Step 1 tests whether you know that dantrolene — not cooling — is the treatment, and why.

From real student decks
97%have cards covering this topic
95%have mature cards
2.0median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Large myelinated motor fibers are blocked first by local anesthetics.
Right: Local anesthetics block small, unmyelinated or lightly myelinated fibers first; the order is pain/temperature (C, Aδ) → autonomic → touch/pressure → motor (Aα last).
The intuition that 'bigger = blocked first' is backwards here. Local anesthetics diffuse more easily into small-diameter, unmyelinated fibers (C fibers carrying pain/temperature) and lightly myelinated fibers (Aδ) than into the large, heavily myelinated Aα motor fibers. Think of it clinically: a patient getting a spinal block loses pain sensation well before they lose motor control. The order is pain/temperature → autonomic → touch/pressure → motor (last).
Common mistake
Wrong: Succinylcholine (depolarizing blocker) can be reversed with neostigmine like nondepolarizing blockers.
Right: Succinylcholine cannot be reversed with neostigmine; it is metabolized by plasma cholinesterase, and giving neostigmine would worsen blockade by increasing ACh at the NMJ.
Neostigmine reverses nondepolarizing blockers by inhibiting acetylcholinesterase, flooding the NMJ with ACh to outcompete the blocker. But succinylcholine IS an ACh analog — it works by binding and keeping the receptor depolarized. Adding neostigmine would increase ACh at the junction, which competes with succinylcholine's metabolism and prolongs the block. Succinylcholine is terminated only by plasma cholinesterase (pseudocholinesterase); there is no pharmacological reversal agent.
Common mistake
Wrong: Malignant hyperthermia is treated with cooling blankets and antipyretics as primary therapy.
Right: Malignant hyperthermia is treated with dantrolene, which blocks ryanodine receptor-mediated Ca2+ release from the sarcoplasmic reticulum; cooling is supportive only.
Malignant hyperthermia is not a fever in the conventional sense — it's a pharmacogenetic hypermetabolic crisis driven by uncontrolled Ca2+ release from the sarcoplasmic reticulum via the ryanodine receptor (RYR1 mutation). This floods skeletal muscle with Ca2+, causing sustained contraction, massive ATP consumption, heat generation, and acidosis. Cooling and antipyretics address the temperature but do nothing about the underlying Ca2+ storm. Dantrolene directly blocks the ryanodine receptor, stopping the cascade at its source.
Common mistake
Wrong: All local anesthetics are metabolized by the liver.
Right: Amide local anesthetics (lidocaine, bupivacaine) are metabolized by the liver, while ester local anesthetics (procaine, tetracaine) are metabolized by plasma cholinesterases.
The 'i' trick: amides have two 'i's in their name (lidocaine, bupivacaine, mepivacaine) and are metabolized by the liver. Esters (procaine, tetracaine, cocaine, benzocaine) are cleaved by plasma cholinesterases. This matters clinically: patients with pseudocholinesterase deficiency will have prolonged ester anesthetic effects (and also prolonged succinylcholine blockade), and patients with hepatic failure may have impaired amide clearance. The exam tests whether you can match the right metabolic pathway to the right drug class.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the mechanism of local anesthetics: they block voltage-gated Na+ channels and do so preferentially in small, unmyelinated fibers — meaning pain and temperature are blocked before touch, pressure, and motor function.
  2. Understand inhaled general anesthetic potency using the concept of MAC (minimum alveolar concentration): lower MAC = higher potency. Know that induction speed depends on blood:gas partition coefficient (lower = faster induction).
  3. Distinguish depolarizing (succinylcholine) from nondepolarizing (rocuronium, vecuronium) NMJ blockers: succinylcholine causes initial fasciculations, cannot be pharmacologically reversed, and is metabolized by plasma cholinesterase.
  4. Recognize malignant hyperthermia: triggered by succinylcholine or volatile anesthetics, caused by uncontrolled ryanodine receptor Ca2+ release from the sarcoplasmic reticulum, and treated with dantrolene — not antipyretics or cooling blankets.

Can you avoid these mistakes?

A patient undergoing spinal anesthesia with lidocaine first reports loss of warmth sensation in their legs. Ten minutes later they still have full leg strength. Which fiber types have been blocked, and which have not? What does this tell you about the order of blockade?
A 25-year-old man with a known pseudocholinesterase deficiency undergoes rapid sequence intubation with succinylcholine. What do you expect to happen, and why? Could you reverse it with neostigmine if the paralysis is prolonged?
A patient in the OR develops a temperature of 41°C, rigid muscles, and rising CO2 within minutes of receiving succinylcholine and halothane. What is the diagnosis, what is the molecular mechanism, and what is the first-line treatment?
You need to choose a local anesthetic for a patient with severe liver disease. Should you choose lidocaine or procaine? Explain your reasoning based on the metabolic pathway of each drug class.

Related topics

Neural Tube Formation and Derivatives Neural Crest Derivatives Neural Tube Defects Other Developmental Malformations

See how your Anki deck covers this topic.

Upload your deck for a free audit →